Chronic ulcerative stomatitis: a distinct clinical entity?

Chronic ulcerative stomatitis (CUS) is a mucocutaneous disorder which is characterised by persistent oral mucosal ulceration. The clinical appearance is often reminiscent of oral lichen planus (OLP) leading to erroneous diagnoses. The immune mediated inhibition of the CUS protein (CUSP) is implicated in the pathogenesis of CUS. CUSP acts as an anti-apoptotic protein and when its action is prevented it may result in significant epithelial injury. The objective or this article is to present the first documented case of CUS in South Africa, with relevant reference to current international literature. CUS should be considered in patients previously diagnosed with OLP but who are unresponsive to glucocorticosteroid therapy. The condition can be successfully managed using hydroxychloroquine.

[1]  S. Sinha,et al.  ELISA test for p63 antibodies in chronic ulcerative stomatitis. , 2010, Oral diseases.

[2]  V. Romano,et al.  Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient , 2010, International Ophthalmology.

[3]  L. Solomon,et al.  Chronic ulcerative stomatitis. , 2008, Oral diseases.

[4]  J. Rinaggio,et al.  A determination of the range of oral conditions submitted for microscopic and direct immunofluorescence analysis. , 2007, Journal of periodontology.

[5]  K. Kirkwood,et al.  Autoimmunity to deltaNp63alpha in Chronic Ulcerative Stomatitis , 2007, Journal of dental research.

[6]  D. Cohen,et al.  Chronic ulcerative stomatitis: diagnostic and management challenges--four new cases and review of literature. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[7]  Vijay Kumar,et al.  Chronic ulcerative stomatitis: clinical, histopathologic, and immunopathologic findings. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[8]  R. Dellavalle,et al.  Characterization of an autoantigen associated with chronic ulcerative stomatitis: the CUSP autoantigen is a member of the p53 family. , 1999, The Journal of investigative dermatology.

[9]  S. Jabłońska,et al.  Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases. , 1998, European journal of dermatology : EJD.

[10]  R. Fox,et al.  Mechanism of action of hydroxychloroquine as an antirheumatic drug. , 1993, Seminars in arthritis and rheumatism.

[11]  E. Beutner,et al.  Chronic ulcerative stomatitis associated with a specific immunologic marker. , 1990, Journal of the American Academy of Dermatology.

[12]  T. Chorzelski [Chronic ulcerative stomatitis (CUS): a new disease entity with specific immunological marker (SES-ANA)]. , 1990, Przeglad dermatologiczny.